RZ-002

N/A

Report date: 2023/10/26 16:58:53

Base Information

Drug NameRZ-002
Drug Alias NameRZ-002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionTelomerase reverse transcriptase modulators
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRznomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRznomics Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A